Golden Helix s End-to-End Solution for Clinical Labs

Similar documents
New Enhancements: GWAS Workflows with SVS

Cancer Gene Panels. Dr. Andreas Scherer. Dr. Andreas Scherer President and CEO Golden Helix, Inc. Twitter: andreasscherer

Analysis with SureCall 2.1

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS

Investigating rare diseases with Agilent NGS solutions

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

The Focused Exome service at Bristol Genetics Laboratory

ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS

DNA-seq Bioinformatics Analysis: Copy Number Variation

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

ACE ImmunoID. ACE ImmunoID. Precision immunogenomics. Precision Genomics for Immuno-Oncology

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST

Figure S4. 15 Mets Whole Exome. 5 Primary Tumors Cancer Panel and WES. Next Generation Sequencing

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Home Brewed Personalized Genomics

NGS ONCOPANELS: FDA S PERSPECTIVE

NGS Types of gene dossier applications UKGTN can evaluate

The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing

Performance Characteristics BRCA MASTR Plus Dx

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC.

Enterprise Interest Thermo Fisher Scientific / Employee

Supplementary Tables. Supplementary Figures

AD (Leave blank) TITLE: Genomic Characterization of Brain Metastasis in Non-Small Cell Lung Cancer Patients

NGS Gateway Lab Services

Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Complete Genomics, Inc.

NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation

NGS IN ONCOLOGY: FDA S PERSPECTIVE

Identifying Mutations Responsible for Rare Disorders Using New Technologies

Benefits and pitfalls of new genetic tests

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Molecular Characterization of Tumors Using Next-Generation Sequencing

Reporting TP53 gene analysis results in CLL

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute

Clinical Utility of Actionable Genome Information in Precision Oncology Clinic

Simple, rapid, and reliable RNA sequencing

Personalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection

DNA Sequence Bioinformatics Analysis with the Galaxy Platform

The 100,000 Genomes Project Harnessing the power of genomics for NHS rare disease and cancer patients

VARIANT PRIORIZATION AND ANALYSIS INCORPORATING PROBLEMATIC REGIONS OF THE GENOME ANIL PATWARDHAN

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library

CS2220 Introduction to Computational Biology

NGS panels in clinical diagnostics: Utrecht experience. Van Gijn ME PhD Genome Diagnostics UMCUtrecht

AACR GENIE Data Guide

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Frequency(%) KRAS G12 KRAS G13 KRAS A146 KRAS Q61 KRAS K117N PIK3CA H1047 PIK3CA E545 PIK3CA E542K PIK3CA Q546. EGFR exon19 NFS-indel EGFR L858R

ISOWN: accurate somatic mutation identification in the absence of normal tissue controls

American Psychiatric Nurses Association

TPMI Presents: Translational Genomics Research Update, Opportunities and Challenges

Cancer troublemakers: a tale of usual suspects and novel villains

Nature Genetics: doi: /ng Supplementary Figure 1. PCA for ancestry in SNV data.

September 23, The Role of In Vitro Diagnostic Tests in Pediatric Master Protocol Development

PSSV User Manual (V1.0)

Counsyl Foresight Carrier Screen. Utmost confidence in every result

TP53 mutational profile in CLL : A retrospective study of the FILO group.

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

Below, we included the point-to-point response to the comments of both reviewers.

Hands-On Ten The BRCA1 Gene and Protein

NGS in neurodegenerative disorders - our experience

Cancer Informatics Lecture

underlying metastasis and recurrence in HNSCC, we analyzed two groups of patients. The

Integration of Cancer Genome into GECCO- Genetics and Epidemiology of Colorectal Cancer Consortium

NGS for Cancer Predisposition

Implementation of BRCA Oncomine panel for germline and somatic variant analysis

Introduction to LOH and Allele Specific Copy Number User Forum

Recherche de variants génomiques en oncologie clinique. Avec des diapos, données & scripts R de: Yannick Boursin, IGR Bastien Job, IGR

Van test naar diagnose naar

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2

AACR GENIE Data Guide

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

No mutations were identified.

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc.

Session 4 Rebecca Poulos

Genome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl.

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression.

Finding subtle mutations with the Shannon human mrna splicing pipeline

Research Strategy: 1. Background and Significance

PMDA Perspectives on Oncology Panel. REIKO YANAGIHARA, Ph.D. Office of In Vitro Diagnostics PMDA

CONTRACTING ORGANIZATION: The Chancellor, Masters and Scholars of the University of Cambridge, Clara East, The Old Schools, Cambridge CB2 1TN

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

Introduction of an NGS gene panel into the Haemato-Oncology MPN service

Introduction. Introduction

Daniel Lieber, Ph.D. Senior Scientist, Computational Biology Foundation Medicine, Cambridge, MA. AACR 2017: Clinical Biomarkers April 3, 2017

Part III of IV: Precision Medicine and Pharmacogenomics. How cancer genomics is causing a radical shift in cancer research and management

National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2011 Formula Grant

Sequencing of 58 STRs using the Illumina ForenSeq TM workflow and analysis of the data with the STRinNGS v.1.0 software

Illuminating the genetics of complex human diseases

Tumor mutational burden and its transition towards the clinic

Data mining with Ensembl Biomart. Stéphanie Le Gras

Genome Wide Variant Analysis of Simplex Autism Families with an Integrative Clinical-Bioinformatics Pipeline

Accel-Amplicon Panels

Comprehensive genomic profiling for various solid tumors

Non-Profit Startup Paradigm Launches Cancer Panel Based on DNA, RNA Sequencing

David Tamborero, PhD

6/12/2018. Disclosures. Clinical Genomics The CLIA Lab Perspective. Outline. COH HopeSeq Heme Panels

Session 4 Rebecca Poulos

Heartland Genetics and Newborn Screening Collaborative Conference

Transcription:

Golden Helix s End-to-End Solution for Clinical Labs Steven Hystad - Field Application Scientist Nathan Fortier Senior Software Engineer 20 most promising Biotech Technology Providers Top 10 Analytics Solution Providers Hype Cycle for Life sciences

Questions during the presentation Use the Questions pane in your GoToWebinar window

Golden Helix Golden Helix is a global bioinformatics company founded in 1998. Variant Calling Filtering and Annotation Clinical Reports CNV Analysis Pipeline: Run Workflows Variant Warehouse Centralized Annotations Hosted Reports Sharing and Integration GWAS Genomic Prediction Large-N-Population Studies RNA-Seq Large-N CNV-Analysis

Cited in over 1,100 peer-reviewed publications

Over 350 customers globally

Golden Helix Who We Are When you choose a Golden Helix solution, you get more than just software REPUTATION TRUST EXPERIENCE INDUSTRY FOCUS THOUGHT LEADERSHIP COMMUNITY TRAINING SUPPORT RESPONSIVENESS INNOVATION and SPEED CUSTOMIZATIONS

Secondary Analysis

Why Sentieon? Pipeline Improvements Why Improve Broad s GATK Haplotype Caller? GATK Haplotype Caller is the most accurate DNA analysis tool Problem: GATK Haplotype Caller is too Slow Solution Consistent: No down-sampling or thread dependency = no run-to-run differences = More accurate No Javascript: low level C More Robust: Can handle joint genotyping on over 100K samples simultaneously without needing a gvcf Software-only Solution: Easily deployable, easily scalable, and easily upgraded. Two Product Lines DNAseq BWA-GATK Haplotype Caller Tnseq MuTect and MuTec2

Performance: Sentieon vs Broad DNAseq TNseq

Proven Accuracy Precision FDA Consistency Challenge - Processed single sample consistency - Single biological sample x two library preps - Top overall performance - Highest reproducibility Truth Challenge - Determine accuracy in Truth Set - Highest indel precision - Highest SNP recall

Proven Accuracy - ICGC-TCGA DREAM Mutation Calling Challenge Evaluates Somatic Variant Call Accuracy SNV INDEL Structural Variants Sentieon 98.57% Sentieon 98.14% Sentieon 100% Bina/Roche 97.57% Bina/Roche 97.01% Genowis 99.82% Genowis 96.92% OICR GSI 86.99% Gridss 99.63% Sentieon leads in all categories

Customizable secondary pipeline CNV caller Sequencer FASTQ Sentieon BAM Linux VCF -Annotate & filter -Clinical reports

CNV and LoH Detection VarSeq Calls CNVs on - Gene Panel Data - Exome Data - Whole Genome Data Faster than CMA and MLPA Utilizes existing coverage data Calls CNVs of every size - Small Single Exon Events - Large Cytogenetic Events

CNV Detection via NGS CNVs are called from coverage data Challenges - Coverage varies between samples - Coverage fluctuates between targets - Systematic biases impact coverage Solutions - Data Normalization - Reference Sample Comparison

CNV calling in VarSeq Reference samples used for normalization Metrics - Z-score: number of standard deviations from reference sample mean - Ratio: sample coverage divided by reference sample mean - VAF: Variant Allele Frequency For Gene Panels and Exomes - Probabilistic model used to call CNVs - Segmentation identifies large cytogenetic events For Whole Genome Data - Targets segmented using Z-scores - Events called based on Z-score and Ratio thresholds

VarSeq Full Clinical Stack

VarSeq Suite Flexible Simple VarSeq Scalable Variant annotation, filtering, and interpretation Rich visualizations with GenomeBrowse built-in Powerful GUI and command-line interfaces Repeatable workflows

Example Workflows Illumina TruSight Cancer Sequencing Panel - Oncogenes & Tumor Suppressor Genes - Drug Targeting Information & Ongoing Clinical Trials Exome Trio Workflow - Casual Variants Associated with Phenotype - Incidental Findings Hereditary Risk Sequencing Panel - Comprehensive coverage of 175 genes with known associations to inherited cardiac conditions, cancers, and other inherited diseases.

Sample Data for Cancer Gene Panels Illumina TruSight Cancer Sequencing Panel - Comprehensive coverage of 154 genes designed to target exons of key tumor suppressor genes and frequently cited oncogenes. - BAM and VCF files for each replicate are available VSReports

VarSeq Demonstration

Sample Data for Exome Trio Workflows NA1278 17-year old Caucasian Women - Admitted for Symptoms of Acute Gastroenteritis. - Serum testing revealed elevated pancreatic enzymes. - Genetic testing revealed Heterozygosity for CFTR gene mutation Δ F508 Incidental Findings NA12892 NA12891 NA12878

VarSeq Demonstration

VSWarehouse Variant Warehouse Server A place to archive full VCFs of every sequenced sample Centralized genomic data hosting, integration with other systems Ask the Variant Warehouse: - Have I ever seen this variant in my previous test samples? - At what frequency? (counts as well) - Does this gene contain other rare variants in my cohort? - Did I provide a pathogenicity assessment for this variant? Has that changed? - Has ClinVar changed since that assessment was initially made? - Have I put this variant into a clinical report for any previous samples?

Integration with VarSeq VarSeq can Export to Warehouse - Create a new Project - Current project template is used - Add Variants to Existing (data only) Annotate with Warehouse Counts - Allele / Genotype counts computed on warehouse variants (or other sources in template). Remote Assessment Catalogs - Customize databases of variant classifications or internal flags like false-positives. Remote Reports - Central versioning of report - Queryable database of all saved reports, with all data in form ready for EMR/LIMS integration

VSWarehouse Centralized Collaboration Project A Project B VSWarehouse Server Group A Group B Collaborators

VSWarehouse Centralized Collaboration

VarSeq Full Clinical Stack

Questions or more info: Email info@goldenhelix.com Request an evaluation of the software at www.goldenhelix.com